1,844 active funding opportunities
Supports atmospheric sciences research via access to advanced instruments and facilities for field and lab studies.
Forecast notice for a Small Business Transition Grant targeting early career scientists, excluding clinical trials.
Funding opportunity from Bureau of Land Management for fire science research. Details on eligibility and funding not provided.
Funding opportunity from FDA for tobacco research data standards, Phase 2. Details and eligibility not specified.
Funding opportunity from FDA to support conferences and scientific meetings without clinical trials.
Funding opportunity from FDA for research on complex generics; clinical trials optional.
Funding opportunity for the INIA Consortia Research Resource with clinical trial optional, announced by NIH.
Opportunity to support youth activism and engagement, offered by U.S. Mission to Albania.
Opportunity to coordinate language access services, deadline May 19, 2026. Details limited.
Opportunity from Dept. of the Army with no specified funding or eligibility details, deadline May 19, 2026.
Opportunity to support initiatives strengthening U.S.-Cyprus relations. Details not provided.
Call for proposals to conduct workshops combating misinformation and disinformation.
Support for strengthening antibiotic resistance surveillance in retail food specimens by FDA.
Opportunity from National Highway Traffic Safety Administration for crash data collection. No detailed info provided.
Annual program statement from U.S. Embassy The Hague with unspecified details and eligibility.
Funding opportunity for the INIA Consortia Administrative Resource Core by NIH, clinical trial optional, deadline May 2026.
Funding opportunity by U.S. Mission to Italy with unspecified details and eligibility.
Opportunity related to the Solomon Islands Threshold Program hosted by Millennium Challenge Corporation.
Funding opportunity for the Integrative Neuroscience Initiative on Alcoholism Consortia by NIH.
Funding opportunity from FDA for REACH Consortium with clinical trials optional. Deadline May 19, 2026.
Funding opportunity to study diastereomers in siRNA drug LEQVIO by FDA, deadline May 19, 2026, no clinical trial allowed.
Notice to renew funding opportunity for Multiple Chronic Disease Research Centers by NIH.
Funding opportunity to support health equity innovation by FDA OMHHE, excluding clinical trials.
Supports programs strengthening U.S.-Italy cultural ties with American elements in education, arts, STEM, and media literacy.
